Literature DB >> 26170388

Restriction of Nonpermissive RUNX3 Protein Expression in T Lymphocytes by the Kozak Sequence.

Byungil Kim1, Yo Sasaki2, Takeshi Egawa3.   

Abstract

The transcription factor Runx3 promotes differentiation of naive CD4(+) T cells into type-1 effector T (TH1) cells at the expense of TH2. TH1 cells as well as CD8(+) T cells express a subset-specific Runx3 transcript from a distal promoter, which is necessary for high protein expression. However, all T cell subsets, including naive CD4(+) T cells and TH2 cells, express a distinct transcript of Runx3 that is derived from a proximal promoter and that produces functional protein in neurons. Therefore, accumulation of RUNX3 protein generated from the proximal transcript needs to be repressed at the posttranscriptional level to preserve CD4(+) T cell capability of differentiating into TH2 cells. In this article, we show that expression of RUNX3 protein from the proximal Runx3 transcript is blocked at the level of translational initiation in T cells. A coding sequence for the proximal Runx3 mRNA is preceded by a nonoptimal context sequence for translational initiation, known as the Kozak sequence, and thus generates protein at low efficiencies and with multiple alternative translational initiations. Editing the endogenous initiation context to an "optimal" Kozak sequence in a human T cell line resulted in enhanced translation of a single RUNX3 protein derived from the proximal transcript. Furthermore, RUNX3 protein represses transcription from the proximal promoter in T cells. These results suggest that nonpermissive expression of RUNX3 protein is restricted at the translational level, and that the repression is further enforced by a transcriptional regulation for maintenance of diverse developmental plasticity of T cells for different effector subsets.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26170388      PMCID: PMC4530074          DOI: 10.4049/jimmunol.1501039

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Plat-E: an efficient and stable system for transient packaging of retroviruses.

Authors:  S Morita; T Kojima; T Kitamura
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

2.  Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development.

Authors:  Ichiro Taniuchi; Motomi Osato; Takeshi Egawa; Mary Jean Sunshine; Suk Chul Bae; Toshihisa Komori; Yoshiaki Ito; Dan R Littman
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

3.  Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons.

Authors:  Ken-ichi Inoue; Shigeru Ozaki; Takashi Shiga; Kosei Ito; Tomoyuki Masuda; Nobuo Okado; Tsutomu Iseda; Saburo Kawaguchi; Masaharu Ogawa; Suk-Chul Bae; Namiko Yamashita; Shigeyoshi Itohara; Norio Kudo; Yoshiaki Ito
Journal:  Nat Neurosci       Date:  2002-10       Impact factor: 24.884

4.  Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage.

Authors:  Kazuyoshi Kohu; Takehito Sato; Shin-Ichiro Ohno; Keitaro Hayashi; Ryuji Uchino; Natsumi Abe; Megumi Nakazato; Naomi Yoshida; Toshiaki Kikuchi; Yoichiro Iwakura; Yoshihiro Inoue; Toshio Watanabe; Sonoko Habu; Masanobu Satake
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  Causal relationship between the loss of RUNX3 expression and gastric cancer.

Authors:  Qing Lin Li; Kosei Ito; Chohei Sakakura; Hiroshi Fukamachi; Ken ichi Inoue; Xin Zi Chi; Kwang Youl Lee; Shintaro Nomura; Chang Woo Lee; Sang Bae Han; Hwan Mook Kim; Wun Jae Kim; Hiromitsu Yamamoto; Namiko Yamashita; Takashi Yano; Toshio Ikeda; Shigeyoshi Itohara; Johji Inazawa; Tatsuo Abe; Akeo Hagiwara; Hisakazu Yamagishi; Asako Ooe; Atsushi Kaneda; Takashi Sugimura; Toshikazu Ushijima; Suk Chul Bae; Yoshiaki Ito
Journal:  Cell       Date:  2002-04-05       Impact factor: 41.582

6.  Runx3 regulates integrin alpha E/CD103 and CD4 expression during development of CD4-/CD8+ T cells.

Authors:  Baerbel Grueter; Michaela Petter; Takeshi Egawa; Kirsten Laule-Kilian; Christine J Aldrian; Andreas Wuerch; Yvonne Ludwig; Hidehiro Fukuyama; Hedda Wardemann; Ralph Waldschuetz; Tarik Möröy; Ichiro Taniuchi; Viktor Steimle; Dan R Littman; Marc Ehlers
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

7.  The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons.

Authors:  Ditsa Levanon; David Bettoun; Catherine Harris-Cerruti; Eilon Woolf; Varda Negreanu; Raya Eilam; Yael Bernstein; Dalia Goldenberg; Cuiying Xiao; Manfred Fliegauf; Eitan Kremer; Florian Otto; Ori Brenner; Aharon Lev-Tov; Yoram Groner
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

8.  The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells.

Authors:  Takeshi Egawa; Robert E Tillman; Yoshinori Naoe; Ichiro Taniuchi; Dan R Littman
Journal:  J Exp Med       Date:  2007-07-23       Impact factor: 14.307

9.  Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf beta binding to the Il4 silencer.

Authors:  Yoshinori Naoe; Ruka Setoguchi; Kaori Akiyama; Sawako Muroi; Masahiko Kuroda; Farah Hatam; Dan R Littman; Ichiro Taniuchi
Journal:  J Exp Med       Date:  2007-07-23       Impact factor: 14.307

10.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre.

Authors:  Jasper de Boer; Adam Williams; George Skavdis; Nicola Harker; Mark Coles; Mauro Tolaini; Trisha Norton; Keith Williams; Kathleen Roderick; Alexandre J Potocnik; Dimitris Kioussis
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

View more
  3 in total

1.  Unique N-terminal sequences in two Runx1 isoforms are dispensable for Runx1 function.

Authors:  Sebastian Nieke; Nighat Yasmin; Kiyokazu Kakugawa; Tomomasa Yokomizo; Sawako Muroi; Ichiro Taniuchi
Journal:  BMC Dev Biol       Date:  2017-10-18       Impact factor: 1.978

Review 2.  Runx Transcription Factors in T Cells-What Is Beyond Thymic Development?

Authors:  Svetlana Korinfskaya; Sreeja Parameswaran; Matthew T Weirauch; Artem Barski
Journal:  Front Immunol       Date:  2021-08-06       Impact factor: 7.561

3.  The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.

Authors:  Yasmina Serroukh; Chunyan Gu-Trantien; Baharak Hooshiar Kashani; Matthieu Defrance; Thien-Phong Vu Manh; Abdulkader Azouz; Aurélie Detavernier; Alice Hoyois; Jishnu Das; Martin Bizet; Emeline Pollet; Tressy Tabbuso; Emilie Calonne; Klaas van Gisbergen; Marc Dalod; François Fuks; Stanislas Goriely; Arnaud Marchant
Journal:  Elife       Date:  2018-02-28       Impact factor: 8.140

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.